OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹208.6 Cr | -15.1% | -21.1% | -26.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,329.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,991.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹126,326.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,126.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,324.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -15.1% |
-21.1% |
-26.7% |
SENSEX | 0.7% |
1.1% |
0.9% |
You may also like the below Video Courses